Moreover, we also found that inhibition of checkpoint kinase 1 (CHK1), the major regulator of the response to impaired DNA replication, significantly increases the toxicity of gemcitabine in Ewing sarcoma cells both in vitro and in vivo [43–45]. The gene discussed is CHEK1; the disease is Ewing sarcoma.